Home » CutiCeuticals Gets Patent for Psoriasis, Eczema Treatment
CutiCeuticals Gets Patent for Psoriasis, Eczema Treatment
CutiCeuticals has been granted a patent for its CutiCort Spray.
The product is a .05 percent clobetasol aerosol spray used for the treatment of psoriasis, eczema and other inflammatory skin conditions.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct